Is Theriva Biologics (TOVX) a buy or sell right now?
Based on aggregated sentiment from Reddit and News sources, Theriva Biologics (TOVX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 22% bullish across 2 active sources. Those sources contribute 22 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
What does Reddit say about TOVX stock?
Reddit discussion around Theriva Biologics (TOVX) is fairly quiet with 21 mentions across 2 tracked subreddits. The tone is 43% bullish with rising momentum, suggesting growing interest over the past week.
What is the sentiment on TOVX stock?
Theriva Biologics (TOVX) sentiment is bearish across all 2 tracked sources. Reddit reads 43% bullish, and news coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Why does TOVX carry a sell signal right now?
Social sentiment data shows consistently bearish discussion around Theriva Biologics (TOVX). All 2 tracked sources lean negative, with news being the most bearish at 0% bullish. Momentum is rising across Reddit and News. The sell signal carries 93/100 conviction.
What is driving Theriva Biologics (TOVX) sentiment right now?
Reddit is the dominant discussion channel with 21 mentions (95% of total volume). News contributes 1 mentions. Sentiment is bearish across all sources, but reddit and news momentum is the only one trending upward, which could signal an early shift.
What does the Adanos sell signal mean for Theriva Biologics (TOVX)?
The Adanos signal blends bullish ratio, buzz score, source breadth, and 7-day momentum into a single buy/sell reading. TOVX's sell signal at 93/100 conviction reflects consistently bearish sentiment across multiple platforms. It is a research shortcut, not financial advice.
How fresh is this TOVX sentiment data?
The TOVX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets, and news articles available in the current publishing cycle.